在进博会,遇见施耐德电气“黑科技”

来源:中新网 编辑:李 丹2019-11-09 15:01:23
浏览

  今天,我们的外企头条继续关注进博会。现在我所在的是进博会的施耐德电气展台。施耐德电气是一家著名的法国企业。对于我们很多人来说,施耐德电气的产品可以说是“看不见,又离不开”。从刚进家门打开的开关面板,到高楼大厦的节能设备,再到整个城市的基础设施和工业制造生产线,处处都有施耐德电气的身影。今年进博会,施耐德电气带来了覆盖电网、工厂、基础设施、楼宇、IT等领域的多项“黑科技”。

  我身边的这个设备就是一个定制的数字饮料生产线。你在选购果汁时,是不是经常有一种每种感觉都不错但是又都算不上最爱的情况呢?有了这个设备,这就不是问题了。通过手机订单页面,你可以根据自己的喜好情况设置各种果汁的配比。具体应用到工厂中时,这个生产线实现了从订单到交付的全透明集成,让工厂的动态全方位可视化,大大提升了工厂的运营效率。

  了解完这个产品,我们再来听一下施耐德电气全球执行副总裁、中国区总裁尹正如何评价进博会。

  尹正:进博会当然是一个非常好的平台,体现了创新、合作和共享,这也和施耐德现在想做的事情是非常相近的,创新(方面)我们有大量的研发,我们在三年会提升50%的研发投入,今天可以看到我们有大量的新的展示、新的解决方案。合作也是,我们有很多合作伙伴,通过这个平台,我们的客户,通过签约,和通过互相的融合,提供更好的解决方案。共享也是,我们大家一块儿把蛋糕做大,不单是在中国,也在海外,包括“一带一路”,包括IT和OT组合,然后我们能够互相共享、共赢。所以整个进博会对施耐德电气来讲是一个非常非常好的一个平台,来支撑我们这个创新、合作和共享。

  利马格兰进博会上展示小麦创新品种

  Limagrain Showcases New Breed Of Wheat At CIIE 2019

  

在进博会,遇见施耐德电气“黑科技”

  作为法国农业食品领域从田间到餐桌的一个典型代表,利马格兰集团首次参加进博会,带来一款20多年选育出来的创新产品:高直链淀粉小麦品种,它的原生膳食纤维含量是标准小麦的十倍。

  As a typical representative of France's from field to table agro-food company , Limagrain Group attended the 2nd CIIE for the first time and presented an innovative product breeded for more than 20 years: a high amylose wheat, of which natural dietary fiber content is ten times that of standard wheat。

  利马格兰是一家农业合作社,由1500名农户组成,这些农户也是利马格兰集团的股东。同时,利马格兰又是一家跨国种业集团,在五大洲56个国家开展业务。

  Limagrain is an agricultural cooperative consisting of 1500 farmers, who are also shareholders of Limagrain Group. At the same time, Lmagrain is a multinational seed group operating in 56 countries on five continents。

  利马格兰高度重视研发和创新,多年来研发投入始终保持在15%左右,大力发展产业链,已经形成了从研发、育种一直到谷物配料和烘焙产品的全谷物产业链。

  Limagrain Group attached great importance to R & D and innovation. It's R & D investment has been maintained at about 15% of its revenue over the years, and it developed an agro-food industry chain: from R&D and seeds to bakery and pastry products。

  这不但在食品安全、可追溯性上有了保障,同时还可以把消费者的需求反馈给育种家,来有针对性地选育符合市场需求的农作物品种。

  This kind of closed industry chain loop ensures not only the food security and good traceability; at the same time, the needs of consumers can also be fed back to breeders to select crop varieties that meet market needs。

  辉瑞携五大领域创新产品集体亮相

  Pfizer Unveiled Collectively The Innovative Products In Five Major Fields

  

在进博会,遇见施耐德电气“黑科技”

  辉瑞公司携肿瘤、抗感染、炎症与免疫、疫苗、罕见病等五大领域创新产品集体亮相第二届进博会。

  Pfizer attends the second CIIE with innovative products in five fields, including oncology, anti-infection, inflammation and immunity, vaccines, and rare diseases。

  作为以研发为基础的创新生物制药企业之一,辉瑞在此次进博会上, 展示出一系列创新药物及治疗方案,多种尚未在中国获批上市的创新药物也相继亮相,让中国乃至世界了解到辉瑞在多个领域的不断创新与进取。

  As one of the innovative biopharmaceutical companies based on R&D, Pfizer presented a series of innovative drugs and therapeutic schedules at the CIIE, with a variety of innovative drugs not yet being approved for marketing in China unveiled, so as to demonstrate to China, as well as the world, Pfizer‘s endeavor in continuous innovation and enterprising in multiple fields。

  今年是辉瑞进入中国的第30年。在进博会上,辉瑞除了展示系列创新药物及治疗方案外,还展示在中国三十年来的发展历程。

  This is the 30th year since Pfizer entered China. Beside a series of innovative medicines and therapeutic schedules, Pfizer also demonstrated its 30 years development in China at this CIIE。

  辉瑞生物制药集团中国区总经理吴琨表示:“我们始终秉持‘为患者带来改变其生活的突破创新’的理念,携手多方共同积极努力推进优秀创新药物的研发及引入。未来,辉瑞将进一步加大和加快在中国新药引进上市的力度和速度,帮助中国的广大患者及时接受与全球同步的先进药物治疗。”

  Wu Kun, Pfizer China Biopharma Country Lead, said: "We always adhere to the concept of "Breakthroughsthat change patients’ lives" and work together to promote the development and introduction of excellent innovative medicine. In the future, Pfizer will further enhance and speed up the introduction and marketing of new drugs in China, and help Chinese patients receive advanced drugs and therapeutic schedules in a timely manner。”

  蔡司展现百年聚焦创新

  ZEISS Demonstrates 100 Years Focusing On Innovation

  

在进博会,遇见施耐德电气“黑科技”

  在第二届进博会上,蔡司延续了“光无界,创无边”的主题,在高端装备展区展出了30余款产品和解决方案。

  At the 2nd CIIE, ZEISS is exhibiting more than 30 of its cutting-edge products and solutions with “Seeing beyond” as its theme in the High-end Equipment area。

  涵盖半导体制造技术、工业质量与研究、医疗技术与消费光学四大领域,再次向展现了蔡司逾百年来聚焦创新,更加注重中国未来发展对创新的需求。